4 news items
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
ABBV
CRBP
CRDL
14 May 24
Impacts
The rescheduling is likely to alleviate financial pressures on cannabis businesses, notably by eliminating certain tax burdens
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
equity investments in public companies, excess tax benefit from share-based compensation, income tax effect of adjusted reconciling items and others
- Prev
- 1
- Next